Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection

Bioanalysis

Volumn 3, Issue 16, 2011, Pages 1847-1853

  Römsing, Susanne ^a,b,c   Lindegardh, Niklas ^d,e   Bergqvist, Yngve ^a,b  

^a DALARNA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Center for Clinical Research Dalarna   (Sweden)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMODIAQUINE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CYCLOGUANIL; HALOFANTRINE; LAMIVUDINE; MEFLOQUINE; METHANOL; NEVIRAPINE; PARACETAMOL; PIPERAQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; PYRONARIDINE; QUININE; SULFADOXINE; SULFAMETHOXAZOLE; TAFENOQUINE; TARTARIC ACID; ZIDOVUDINE;

ACCURACY; ARTICLE; CAPILLARY BLOOD; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; PLASMA; PROCESS DEVELOPMENT; PRODUCT RECOVERY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

AMINOQUINOLINES; ANTIMALARIALS; CHROMATOGRAPHY, LIQUID; DRIED BLOOD SPOT TESTING; HUMANS; SOLID PHASE EXTRACTION;

EID: 80052447700     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.173     Document Type: Article

References (29)

1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64(Suppl.1-2), 97-106 (2001). (Pubitemid 32552576)
2. Walsh DS, Wilairatana P, Tang DB et al. Randomized trial of 3-dose regimens of tafenoquine (WR 238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clin. Infect. Dis. 39(8), 1095-1103 (2004). (Pubitemid 40169305)
3. Nasveld PE, Edstein MD, Reid M et al. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob. Agents Chemother. 54(2), 792-798 (2010).
4. Shanks GD, Oloo AJ, Aleman GM et al. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin. Infect. Dis. 33(12), 1968-1974 (2001). (Pubitemid 33152389)
5. Walsh DS, Eamsila C, Sasiprapha T et al. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. J. Infect. Dis. 190(8), 1456-1463 (2004). (Pubitemid 39332185)
6. Clayman CB, Arnold J, Hockwald RS, Yount EH Jr, Edgcomb JH, Alving AS. Toxicity of primaquine in caucasians. J. Am. Med. Assoc. 149(17), 1563-1568 (1952).
7. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull. World Health Organ. 59(3), 391-395 (1981). (Pubitemid 11024762)
8. Elmes NJ, Nasveld PE, Kitchener SJ, Kocisko DA, Edstein MD. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the southwest pacific. Trans. R. Soc. Trop. Med. Hyg. 102(11), 1095-1101 (2008).
9. Brueckner RP, Lasseter KC, Lin ET, Schuster BG. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am. J. Trop. Med. Hyg. 58(5), 645-649 (1998). (Pubitemid 28237265)
10. Charles BG, Miller AK, Nasveld PE, Reid MG, Harris IE, Edstein MD. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrob. Agents Chemother. 51(8), 2709-2715 (2007). (Pubitemid 47206203)
11. Edstein Md, Kocisko DA, Brewer TG, Walsh DS, Eamsila C, Charles BG. Population pharmacokinetics of the new antimalarial agent tafenoquine in thai soldiers. Br. J. Clin. Pharmacol. 52(6), 663-670 (2001). (Pubitemid 34015624)
12. Kocisko DA, Walsh DS, Eamsila C, Edstein MD. Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography. Ther. Drug Monit. 22(2), 184-189 (2000). (Pubitemid 30196823)
13. Karle JM, Olmeda R. Rapid and sensitive quantitative analysis of the new antimalarial N4-[2,6-dimethoxy-4-methyl-5-[(3- trifluoromethyl)phenoxy]-8- quinolinyl]-1,4- pentanediamine in plasma by liquid chromatography and electrochemical detection. J. Chromatogr. 424(2), 347-356 (1988). (Pubitemid 18058848)
14. Karle JM, Olmeda R, Freeman SG, Schroeder AC. Quantification of the individual enantiomer plasma concentrations of the candidate antimalarial agent N4-[2,6- dimethoxy-4-methyl-5-[(3-trifluoromethyl) phenoxy]-8-quinolinyl]-1,4- pentanediamine (WR 238,605). J. Chromatogr. B Biomed. Appl. 670(2), 251-257 (1995).
15. Doyle E, Fowles SE, Summerfield S, White TJ. Rapid determination of tafenoquine in small volume human plasma samples by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 769(1), 127-132 (2002). (Pubitemid 34188388)
16. Fast DM, Kelley M, Viswanathan CT et al. Workshop report and follow-up - AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples - implications of Crystal City recommendations. AAPS J. 11(2), 238-241 (2009).
17. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays. Pharm. Res. 24(10), 1962-1973 (2007). (Pubitemid 47389236)
18. Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration MD, USA.
19. Savoie N, Garofolo F, Van Amsterdam P et al. 2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group workshop. Bioanalysis 2(1), 53-68 (2009).
20. Bergqvist Y, Funding L, Kaneko A, Krysen B, Leek T. Improved method for the simultaneous determination of proguanil and its metabolites by high-performance liquid chromatography and solid-phase extraction of 100-microl capillary blood samples dried on sampling paper. J. Chromatogr. B Biomed. Sci. Appl. 719(1-2), 141-149 (1998).
21. Blessborn D, Romsing S, Annerberg A et al. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J. Pharm. Biomed. Anal. 45(2), 282-287 (2007).
22. Blessborn D, Romsing S, Bergqvist Y, Lindegardh N. Assay for screening for six antimalarial drugs and one metabolite using dried blood spot sampling, sequential extraction and ion-trap detection. Bioanalysis 2(11), 1839-1847 (2010).
23. Spooner N, Ramakrishnan Y, Barfield M, Dewit O, Miller S. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis 2(8), 1515-1522 (2010).
24. Evengard B, Von Sydow M, Ehrnst A, Pehrson PO, Lundbergh P, Linder E. Filter paper sampling of blood infected with HIV: effect of heat on antibody activity and viral infectivity. BMJ (Clinical Research) 297(6657), 1178 (1988). (Pubitemid 18263990)
25. Ursing J, Kofoed PE, Rodrigues A, Bergqvist Y, Rombo L. Chloroquine is grossly overdosed and overused but well tolerated in Guinea-Bissau. Antimicrob. Agents Chemother. 53(1), 180-185 (2009).
26. Malm M, Lindegardh N, Bergqvist Y. Automated solid-phase extraction method for the determination of piperaquine in capillary blood applied onto sampling paper by liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 809(1), 43-49 (2004). (Pubitemid 38998418)
27. Lindegardh N, Funding L, Bergqvist Y. Automated solid-phase extraction method for the determination of atovaquone in capillary blood applied onto sampling paper by rapid high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 758(2), 137-144 (2001). (Pubitemid 32524009)
28. Kaneko A, Bergqvist Y, Takechi M et al. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil. J. Infect. Dis. 179(4), 974-979 (1999). (Pubitemid 29159344)
29. Hietala SF, Bhattarai A, Msellem M et al. Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria. J. Pharmacokinet. Pharmacodyn. 34(5), 669-686 (2007). (Pubitemid 47477038)